Oramed Pharmaceuticals (ORMP) Positive Results from Trial for

Message Board

| Next

Post# of 54

Posted On: 01/30/2014 8:17:26 AM

Posted By: riddock57

Oramed Pharmaceuticals Inc. (ORMP)

Insulin is a hormone produced in the pancreas by special cells, called beta cells. The pancreas is behind the stomach. Insulin is needed to move blood sugar (glucose) into cells. There, it is stored and later used for energy

Diabetes is a group of diseases marked by high levels of blood glucose resulting from defects in insulin production, insulin action, or both. Diabetes can lead to serious complications and premature death, but people with diabetes can take steps to control the disease and lower the risk of complications.

Type 2 diabetes, characterized by high blood glucose in the context of insulin resistance and relative insulin deficiency, is the most common form of diabetes, affecting 90% to 95% of the 26 million Americans with diabetes.

ORMP reported positive results from its Phase 2a clinical trial for its ORMD-0801 oral insulin capsule for the treatment of type 2 diabetes.

The Phase 2a study, conducted under an FDA Investigational New Drug protocol, met all primary and secondary endpoints.

ORMP 's ORMD-0801 is an orally ingestible insulin capsule for the early stages of type 2 diabetes, when it can still slow the rate of degeneration of the disease by providing additional insulin to the body and allowing pancreatic respite. Moreover, orally administered insulin has the potential benefit of enhanced patient compliance at this crucial stage as well as the advantage of mimicking insulin's natural location and gradients in the body by first passing through the liver before entering the bloodstream.

ORMP is a technology pioneer in the field of oral delivery solutions for drugs and vaccines currently delivered via injection.

More about Oramed Pharmaceuticals Inc. (ORMP) at www.oramed.com

Crown Equity Holdings Inc. (CRWE)

Social networking is the simple act of expanding the number of people you know by meeting your friends' friends, their friends' friends and so on.

Web-based social networking services make it possible to connect people who share interests and activities across political, economic, and geographic borders

CRWE is looking to deliver value for its stockholders in both the near and long term, and to improve the potential future growth for the company, is targeting the multi-billion dollar social networking service market.

CRWE is currently developing a social networking service and phone app, CRWE Network ( www.CRWE-PR.com ), that is designed to target all the communities in every state of the United States, with its geographic focus starting in Southern California and Las Vegas Nevada, and all the communities in every state of Canada, starting in Montreal ( www.montrealcanada.crwe-pr.com ), Calgary ( www.calgarycanada.crwe-pr.com ), Vancouver ( www.vancouvercanada.crwe-pr.com ), Edmonton ( www.edmontoncanada.crwe-pr.com ) and Kamloops ( www.kamloopscanada.crwe-pr.com ).

CRWE ‘s business plan is based on selling advertising to local businesses. Its goal is to facilitate exchanges of goods and services in a manner similar to Craigslist, a classified advertisements website with sections devoted to jobs, housing, personals, for sale, items wanted, services, community, gigs, résumés, and discussion forums.

CRWE offers advertising branding and marketing services as a worldwide online multi-media publisher.

More about Crown Equity Holdings Inc. (CRWE) at www.crownequityholdings.com .

Mecox Lane Limited (MCOX)

Keep a close eye on MCOX, which reported that Cnshangquan E-Commerce Co., Ltd., a Nanjing-based leading provider of integrated marketing platforms for businesses and consumers, has agreed to purchase approximately 63.7% of the issued and outstanding ordinary shares of the Company from several existing shareholders, for a total cash consideration of approximately US$39 million in a private transaction intended to be exempt from the registration requirements under the Securities Act of 1933.

The transactions contemplated by the share purchase agreement will result in a change in control of the Company upon consummation.